5 Results for "

Alisertib

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "Alisertib" in MCE Product Catalog:

75
75 Publications Verification
Cat. No.: HY-10971
CAS No.: 1028486-01-2
Purity:  99.36%
Synonyms: MLN 8237
Research Areas:  

Cancer

Alisertib (MLN 8237) is an orally active and selective Aurora A kinase inhibitor (IC50=1.2 nM), which binds to Aurora A kinase resulting in mitotic spindle abnormalities, mitotic accumulation. Alisertib (MLN 8237) induces apoptosis and autophagy through targeting the AKT/mTOR/AMPK/p38 pathway in leukemic cells. Antitumor activity .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-141512
CAS No.: 2705844-82-0
Purity:  98.97%
Target:  

PROTACs Aurora Kinase

Research Areas:  

Cancer

JB170 is a potent and highly specific PROTAC-mediated AURORA-A (Aurora Kinase) degrader (DC50=28 nM) by linking Alisertib, to the Cereblon-binding molecule Thalidomide. JB170 preferentially binds AURORA-A (EC50=193 nM) over AURORA-B (EC50=1.4 µM). JB170-mediated S-phase arrest is caused specifically by AURORA-A depletion. JB170 has excellent ability to inhibit non-catalytic function of AURORA-A kinase .
loading...
    loading...
Cat. No.: HY-125956
CAS No.: 1534060-58-6
Purity:  ≥98.0%
Target:  

Aurora Kinase Apoptosis

Research Areas:  

Cancer

Aurkin A is an allosteric inhibitor for the interaction between Aurora A Kinase (also known also Aurka) and TPX2, through targeting the TPX2 binding sites with Kd of 3.77 μM. Aurkin A can disrupt polyploidy induced by Alisertib (HY-10971) and increase apoptosis of tumor cells. Aurkin A can be used in research on mitosis and cancer .
loading...
    loading...
Cat. No.: HY-10971A
CAS No.: 1028486-06-7
Synonyms: MLN 8237 sodium
Research Areas:  

Cancer

Alisertib (MLN 8237) sodium is an orally active and selective Aurora A kinase inhibitor (IC50=1.2 nM), which binds to Aurora A kinase resulting in mitotic spindle abnormalities, mitotic accumulation. Alisertib sodium induces apoptosis and autophagy through targeting the AKT/mTOR/AMPK/p38 pathway in leukemic cells. Antitumor activity .
loading...
    loading...
Cat. No.: HY-10971R
CAS No.: 1028486-01-2
Synonyms: MLN 8237 (Standard)
Research Areas:  

Cancer

Alisertib (Standard) is the analytical standard of Alisertib. This product is intended for research and analytical applications. Alisertib (MLN 8237) is an orally active and selective Aurora A kinase inhibitor (IC50=1.2 nM), which binds to Aurora A kinase resulting in mitotic spindle abnormalities, mitotic accumulation. Alisertib (MLN 8237) induces apoptosis and autophagy through targeting the AKT/mTOR/AMPK/p38 pathway in leukemic cells. Antitumor activity .
loading...
    loading...